Hypersensitivity Disorders Flashcards
Type I
Mediated by IgE and results from mediators secreted by mast cells
Type II
Mediated by Abs that bind tissue Ags and cause complement-dependent tissue injury and disease
Type III
Mediated by circulating Ab-Ag complexes which deposit in vessels and cause complement-dependent injury in the vessel wall (vasculitis)
Type IV
Mediated by T cells and results from inflammation caused by cytokines released by Th1 and Th17 cells, macrophages, or killing of host cells by CD8 CTLs
-Also known as DTH delayed type hypersensitivity
Histamine function
Dilation of small vessels and vascular permeability
Protease, prostaglandins, leukotrienes, cytokines all do what
Proteases- cause local tissue damage
Prostaglandins- Vascular dilation
Leukotrienes- Smooth muscle contraction
Cytokines- local inflammation
Sequence of events in immediate hypersensitivity reactions (type I)
Primary exposure to allergen activates Th2 cells and IgE is produced
Binding of IgE to Fce receptors- patient is sensitized
Secondary exposure- Ag dependent cross-linking of membrane bound IgE causes activation of mast cells and release of inflammatory mediators
Immediate vs late phase reaction in Type I
Immediate vascular/smooth muscle reactions characterized by vasodilation, congestion, edema
Late phase- 2-24hrs later- inflammatory infiltrate rich in eosinophils, neutrophils and T cells
Anaphylaxis
Food allergen exposure causes massive release of vasoactive amines/cytokines from mast cells throughout body
Drop in blood pressure resulting in vascular shock
Contraction of smooth muscle in bronchi making breathing difficult
Key mechanism of allergen specific immunotherapy
Generation of induced regulatory Treg cells
Type II hypersensitivity method of action
IgG/IgM Abs activated complement system resulting in C3a/C5a production
Neutrophil/macrophages activated in FcR/CR1 dependent manner release ROS/lysosomal enzymes causing damage
Graves disease/myasthenia gravis cause
Abs bind and stimulate activity of TSH receptors even in absence of TSH- Graves
Abs inhibit binding of Ach to Ach receptor causing myasthenia gravis
Penicillin induced anemia
Drug binds directly to erythrocyte surface and induces anti-drug Ab
Improves after stopping Abx
Quanidine induced anemia
Autoantibodies form immune complexes with drug
Complexes bind erythrocyte surface through CR1
May require immunosuppression/plasmapheresis to remove complexes
Methyldopa induced anemia
Drug induces antidrug Ab that cross reacts with an Rh antigen